News Archive

Vitamins D and K are powerful nutrients in their own right, but their potential effects in combination may be where their real strength is found.

Read more

At Vitafoods Europe, Balchem Human Nutrition and Health and its recently acquired Kappa Bioscience are showcasing synergies between their portfolios and opportunities for innovation. 

Read more

Kappa Bioscience, a leading manufacturer of vitamin K2 under the brand name K2Vital, is introducing “the first” USDA organic-certified all-trans, all-bioactive vitamin K2-MK7 for oil-based health applications on the US market.

Read more

There was a protective role identified of K2VITAL DELTA vitamin K2 MK-7 and vitamin D in individuals at risk of coronary artery calcification

Read more

Kappa Bioscience, the leading manufacturer of vitamin K2 under the brand name K2VITAL, has announced the appointment of Dr John E. Repine MD as the newest member of its “Blue Ribbon” Scientific and Medical Advisory Board.

Read more

Understanding vitamin K2 cis- vs trans-bonds impact on product quality.

Read more

The world is full of iconic duos that combine to become more than the sum of their parts. One relatively unknown yet equally powerful partnership is that of vitamins D3 and K2.

Read more

Kappa Bioscience, the leading manufacturer of vitamin K2 under the brand name K2VITAL, announces that the previously announced acquisition from Balchem Corporation is now complete.

Read more

Balchem Corporation, a global specialty ingredients company focused on nutrition and health, has signed a definitive agreement to acquire Kappa Bioscience AS, a leading science-based manufacturer of specialty vitamin K2 for the human nutrition industry, headquartered in Oslo, Norway

Read more

Kappa Bioscience to discuss vitamin K2 and D synergy at Vitafoods

Read more

Kappa Bioscience announces the appointment of Rena Cohen-First as Vice President of Sales North America.with new Vice President of sales in North America

Read more

Kappa Bioscience announced today the formation of a "Blue Ribbon" Scientific and Medical Advisory Board to support and expand the scientific knowledge base for Vitamin K2.

More details

Kappa Bioscience, Norway-based company and global leader for pure and stable vitamin K2 MK-7, K2VITAL^® ingredients, is expanding its business in the United States.

Press release

The company announces a new agreement with Canisius Wilhelmina Hospital, Nijmegen, The Netherlands, that covers funding of a PhD grant and execution of a clinical trial.

Press Release

The Norwegian company recently announced its entire workforce went climate-positive from 2021 onwards. Through its cooperation with Ecologi, the company offers its employees to balance their carbon emissions – and more.

Press release

On 29 July, the coming NBJ summit will focus on two key themes: climate action and immune health. Kappa Bioscience, global authority for vitamin K2 MK-7 ingredients, is sponsoring the event, in line with their recent developments.

Press release

Following a recent IPCC publication, Norwegian vitamin K2 expert Kappa Bioscience reveals a resolute ‘Brand & Plant’ program.

Press release

The Kappa Bioscience Group introduces Kappa Solutions, its subsidiary for custom organic synthesis and analytical services for the pharmaceutical and dietary supplements industries. The Norwegian leader for vitamin K2 ingredients renames its sister company, previously known as Synthetica, now Kappa Solutions.

Press release